132 related articles for article (PubMed ID: 23261476)
41. Time-to-tumour risk assessment for 1,3-butadiene based on exposure of mice to low doses by inhalation.
Dankovic DA; Smith RJ; Stayner LT; Bailer AJ
IARC Sci Publ; 1993; (127):335-44. PubMed ID: 8070880
[TBL] [Abstract][Full Text] [Related]
42. Airborne occupational exposures and risk of oesophageal and cardia adenocarcinoma.
Jansson C; Plato N; Johansson AL; Nyrén O; Lagergren J
Occup Environ Med; 2006 Feb; 63(2):107-12. PubMed ID: 16421388
[TBL] [Abstract][Full Text] [Related]
43. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
[TBL] [Abstract][Full Text] [Related]
44. 1,3-Butadiene, styrene and selected outcomes among synthetic rubber polymer workers: Updated exposure-response analyses.
Sathiakumar N; Bolaji B; Brill I; Chen L; Tipre M; Leader M; Arora T; Delzell E
Chem Biol Interact; 2021 Sep; 347():109600. PubMed ID: 34324853
[TBL] [Abstract][Full Text] [Related]
45. Leukemia in relation to occupational exposures to benzene and other agents: a case-control study nested in a cohort of gas and electric utility workers.
Guénel P; Imbernon E; Chevalier A; Crinquand-Calastreng A; Goldberg M
Am J Ind Med; 2002 Aug; 42(2):87-97. PubMed ID: 12125084
[TBL] [Abstract][Full Text] [Related]
46. 1,3-butadiene: cancer, mutations, and adducts. Part V: Hemoglobin adducts as biomarkers of 1,3-butadiene exposure and metabolism.
Swenberg JA; Christova-Gueorguieva NI; Upton PB; Ranasinghe A; Scheller N; Wu KY; Yen TY; Hayes R
Res Rep Health Eff Inst; 2000 Mar; (92):191-210; discussion 211-9. PubMed ID: 10925842
[TBL] [Abstract][Full Text] [Related]
47. Dithiocarbamates as potential confounders in butadiene epidemiology.
Irons RD; Pyatt DW
Carcinogenesis; 1998 Apr; 19(4):539-42. PubMed ID: 9600335
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of frequencies of HPRT mutant lymphocytes in butadiene polymer workers in a Southeast Texas facility.
Wickliffe JK; Ammenheuser MM; Adler PJ; Abdel-Rahman SZ; Ward JB
Environ Mol Mutagen; 2009 Mar; 50(2):82-7. PubMed ID: 19107895
[TBL] [Abstract][Full Text] [Related]
49. A pharmacokinetic model to describe toxicokinetic interactions between 1,3-butadiene and styrene in rats: predictions for human exposure.
Filser JG; Johanson G; Kessler W; Kreuzer PE; Stei P; Baur C; Csanády GA
IARC Sci Publ; 1993; (127):65-78. PubMed ID: 8070888
[TBL] [Abstract][Full Text] [Related]
50. Leukemia risk associated with low-level benzene exposure.
Glass DC; Gray CN; Jolley DJ; Gibbons C; Sim MR; Fritschi L; Adams GG; Bisby JA; Manuell R
Epidemiology; 2003 Sep; 14(5):569-77. PubMed ID: 14501272
[TBL] [Abstract][Full Text] [Related]
51. Measurement of plasma or urinary metabolites and Hprt mutant frequencies following inhalation exposure of mice and rats to 3-butene-1,2-diol.
Walker DM; McDonald JD; Meng Q; Kracko DA; Bauer MJ; Seilkop SK; Walker EL; Henderson RF; Walker VE
Chem Biol Interact; 2007 Mar; 166(1-3):191-206. PubMed ID: 17316587
[TBL] [Abstract][Full Text] [Related]
52. Styrene exposure and ischemic heart disease: a case-cohort study.
Matanoski GM; Tao XG
Am J Epidemiol; 2003 Nov; 158(10):988-95. PubMed ID: 14607807
[TBL] [Abstract][Full Text] [Related]
53. A review of the epidemiology of 1,3-butadiene and chloroprene.
Acquavella JF; Leonard RC
Chem Biol Interact; 2001 Jun; 135-136():43-52. PubMed ID: 11397380
[TBL] [Abstract][Full Text] [Related]
54. 1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene.
Blair IA; Oe T; Kambouris S; Chaudhary AK
Res Rep Health Eff Inst; 2000 Mar; (92):151-90; discussion 211-9. PubMed ID: 10925841
[TBL] [Abstract][Full Text] [Related]
55. Epidemiological studies of styrene-exposed populations.
Coggon D
Crit Rev Toxicol; 1994; 24 Suppl():S107-15. PubMed ID: 7818767
[TBL] [Abstract][Full Text] [Related]
56. Carcinogenicity of 1,3-butadiene.
Melnick RL; Shackelford CC; Huff J
Environ Health Perspect; 1993 Apr; 100():227-36. PubMed ID: 8354171
[TBL] [Abstract][Full Text] [Related]
57. Styrene Exposure and Risk of Lymphohematopoietic Malignancies in 73,036 Reinforced Plastics Workers.
Christensen MS; Vestergaard JM; d'Amore F; Gørløv JS; Toft G; Ramlau-Hansen CH; Stokholm ZA; Iversen IB; Nissen MS; Kolstad HA
Epidemiology; 2018 May; 29(3):342-351. PubMed ID: 29533250
[TBL] [Abstract][Full Text] [Related]
58. Lymphohematopoietic cancer in styrene-butadiene polymerization workers.
Santos-Burgoa C; Matanoski GM; Zeger S; Schwartz L
Am J Epidemiol; 1992 Oct; 136(7):843-54. PubMed ID: 1442750
[TBL] [Abstract][Full Text] [Related]
59. The effect of uncertainty in exposure estimation on the exposure-response relation between 1,3-butadiene and leukemia.
Graff JJ; Sathiakumar N; Macaluso M; Maldonado G; Matthews R; Delzell E
Int J Environ Res Public Health; 2009 Sep; 6(9):2436-55. PubMed ID: 19826555
[TBL] [Abstract][Full Text] [Related]
60. [Paradigm change in the assessment of myeloid and lymphoid neoplasms associated with occupational benzene exposure].
Beelte S; Haas R; Germing U; Jansing PJ
Med Klin (Munich); 2009 Mar; 104(3):197-203. PubMed ID: 19337709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
